Komori
PhoenixBio (6190) · InitiativeUpdate to outstanding stock options

Issuance of Stock Options to Employees

First written in FY2022-Q2. . Latest entry: FY2026.

3entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2022-Q2 – FY20262021: 12022: 020222023: 120232024: 020242025: 020252026: 12026
Same theme, other companies
Grant and Issuance of Equity Compensation to Employees and Officers (Stock Options and Restricted Stock)A theme 658 companies write about · 0 as a headwind · 739 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 179 companies compared. The sentences above are computed from all 179.Comparing 200 of the theme's 741 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Update to outstanding stock optionsAnnual report

    「Forfeited 1,000 Outstanding and unexercised 56,000」

    Of the 22nd Series of Stock Acquisition Rights issued to employees, rights covering 1,000 shares were forfeited, leaving 56,000 shares outstanding and unexercised. The exercise period is from 16 September 2023 to 15 September 2028.
  2. FY2023Update to outstanding stock optionsAnnual report

    「22nd Series of Stock Acquisition Rights Before vesting            (shares) End of previous consolidated fiscal year 59,000 Granted - Forfeited 2,000 Vested - Unvested balance 57,000」

    Of the stock options issued to employees, rights covering 2,000 shares were forfeited, leaving an unvested balance covering 57,000 shares. The exercise period is from 16 September 2023 to 15 September 2028.
  3. FY2022-Q2First statedAnnual report

    「The company resolved at a meeting of the Board of Directors held on 15 September 2021 to issue stock options to its employees and issued them on 1 October 2021. The purpose was to increase employees’ motivation and morale to improve the company’s performance and enhance corporate value. ② Categories and number of eligible persons Company employees: 43 ⑤ Class and number of shares underlying the stock acquisition rights 59,000 common shares of the company (100 shares per stock acquisition right) ⑥ Amount payable upon exercise of the stock acquisition rights ¥688 per share ⑨ Exercise period of the stock acquisition rights From 16 September 2023 to 15 September 2028」

    On 1 October 2021, the company issued stock options covering 59,000 shares to 43 employees. The purpose was to increase motivation and morale to improve performance and enhance corporate value; the exercise price and exercise period were also specified.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for PhoenixBio yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Issuance of Stock Options to Employees | PhoenixBio Co.,Ltd. (6190) | Komori